Terns Pharmaceuticals to Present Preclinical Data on Two Lead Programs at the European Association for the Study of the Liver (EASL) Annual Meeting 2019

TERN-101 Demonstrated Potency as an Agonist of FXR Nuclear Hormone Receptor TERN-201 Demonstrated Potency as an Inhibitor of SSAO (VAP-1)[…]

Read more

Mitsui Chemicals and Chitose Group Launch Novel Open Innovation Initiative to Foster Businesses and Talents

Bringing Together Unique Technologies for Joint Commercialization TOKYO–(BUSINESS WIRE)–Oct. 29, 2018 Mitsui Chemicals, Inc. (TOKYO:4183)(President & CEO: Tsutomu Tannowa) and[…]

Read more

JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes

Immediate reduction in nicotine content is the clear winner WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–Sep. 05, 2018 22nd Century Group, Inc. (NYSE American:[…]

Read more

Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia

Results showed a significant reduction in transfusion burden compared to placebo Safety profile generally consistent with previously reported data Regulatory[…]

Read more
1 2